QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN-5-HT6 RECEPTOR

The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. In formula (I) R is a moiety...

Full description

Saved in:
Bibliographic Details
Main Authors DRESCHER KARLA, UNGER LILIANE, WICKE KARSTEN, TURNER SEAN COLM, BRAJE WILFRIED, LANGE UDO, MEZLER MARIO, MAYRER MATTHIAS, HAUPET ANDREAS, WERNET WOLFGANG, NAGER-WERNET ANDREA
Format Patent
LanguageEnglish
Published 03.01.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. In formula (I) R is a moiety of the formula (R) wherein * indicates the binding site to the quinolinyl radical and wherein A, B, X′, Y, Q, R1, R2, R3, R4, R5, m, n, p, q, Ra, Rb, X and Ar are as defined in claim 1.
Bibliography:Application Number: US201213613344